[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Diabetes Market Research Reports & Industry Analysis

The notion “diabetes” refers to a disease impacting the body’s ability to produce/use insulin. At present, more than 365 million people suffer from the disease worldwide. By 2030, the figure may reach 550 million. Inappropriate eating habits combined with a sedentary lifestyle, growth of the diabetic population and an increase in the number of obesity cases are amid the main factors contributing to the diabetes market growth. The list of the products available on the market is extensive: continuous blood glucose meters, anti-diabetic drugs, insulin and insulin pumps, artificial pancreas devices, etc.

Evaluated at over USD 19.8 billion, North America represents the top market, while Europe acts as the second largest player. The global diabetes market is expected to be at approximately USD 100 billion in 2018, showing a twofold increase if compared to 2011.

The Catalogue includes research reports dedicated to the diabetes market. The studies describe past and current industry trends, disclose data on the market competition and profile top industry behemoths. Information on the upcoming market events, industry growth drivers and hindrances can be found in the reports, too. Besides, the research reports contain evaluation of the actual economic situation, analyses of the market prospects.

Publications found: 67
Sort by:

Global Diabetes Insulin Delivery Pen Market 2022: Insights, Trends, Competition, Growth Opportunities, Market Size, Market Share Data, Analysis Outlook and Forecast to 2028

US$ 1,393.00

Amid the COVID-19 crisis, the global diabetes insulin delivery pen market size is expected to grow from an estimated value of USD 16,975 million in 2022 to USD 22,170 million by 2028. After conducting...

September 2022 290 pages

Diabetes Associated Ophthalmic Treatment Market Size, Share & Trends Analysis Report By Type (Drugs, Devices), By Application (Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract), By End-use, By Region, And Segment Forecasts, 2021 - 2028

US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Diabetes Associated Ophthalmic Treatment Market Growth & Trends The global diabetes associated ophthalmic treatment market size i...

October 2021 178 pages

Diabetic Socks Market Size, Share & Trends Analysis Report By Product (Ankle Length, Calf Length, Knee Length), By Distribution Channel (Hypermarkets, E-commerce), By Region, And Segment Forecasts, 2020 - 2027

US$ 3,950.00

This report can be delivered to the clients within 48 Business Hours Diabetic Socks Market Growth & Trends The global diabetic socks market size is anticipated to reach USD 303.2 million by 2027, ac...

August 2020 80 pages

Outlook of Diabetic Macular Edema – Current Landscape and the Way Forward

US$ 4,500.00

Outlook of Diabetic Macular Edema – Current Landscape and the Way Forward: LONG-LASTING VEGF BLOCKERS, COMPOUNDS WITH VEGF- INDEPENDENT MECHANISM AND, TOPICAL AND ORAL TREATMENT OPTIONS, BRING THE QUE...

June 2020 81 pages

The 2021-2026 World Outlook for Molded Dual-Component Cushioned-Ring Flexible Seals That Are Backed, Constrained, or Loaded by an Elastomeric Ring

US$ 995.00

This study covers the world outlook for molded dual-component cushioned-ring flexible seals that are backed, constrained, or loaded by an elastomeric ring across more than 190 countries. For each year reported, estimates are given for the latent ...

December 2019 328 pages

The 2021-2026 World Outlook for Naturally Occurring Vitamins in Bulk Excluding Vitamin C and Vitamin E

US$ 995.00

This study covers the world outlook for naturally occurring vitamins in bulk excluding vitamin C and vitamin E across more than ... P.I.E., for naturally occurring vitamins in bulk excluding vitamin C and vitamin E. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

December 2019 316 pages

The 2021-2026 World Outlook for Non-Aerospace-Type High-Pressure Hydraulic Fluid Filter Assemblies for Fluid Power Transfer Systems with at Least 3,000 P.s.i.

US$ 995.00

This study covers the world outlook for non-aerospace-type high-pressure hydraulic fluid filter assemblies for fluid power transfer systems with at least 3,000 p.s.i. across more than 190 countries. For each year reported, ...

December 2019 334 pages

Digital Diabetes Management Market - Global Outlook and Forecast 2019-2024

US$ 3,500.00

The global digital diabetes management market is growing at a CAGR of over 18% during the forecast period 2018–2024. The global digital diabetes management market has witnessed significant growth in s...

November 2019 268 pages

Global Type 2 Diabetes Treatment Market Research and Forecast, 2018-2023

US$ 3,600.00

... treatment therapies for diabetes and a strict regulatory framework that hamper the growth of the global type 2 diabetes market. Based on the region, the global type 2 diabetes ... of the World. North America dominates the global type 2 diabetes market owing to technological advancements and supportive government ...

January 2019

Diabetic Foot Ulcer (DFU) Market & Drug Pipeline Analysis - Forecast to 2025

US$ 4,950.00

“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The ... research for DFU. Market Data Forecasting model for DFU market DFU market dynamics DFU Market Sizing DFU related deals & Funding scenario in DFU market Pipeline Analysis ...

December 2018 136 pages

Global Diabetic Neuropathy Market Size study, by Types of Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), and by Regional Forecasts 2018-2025

US$ 3,150.00

Global Diabetic Neuropathy Market to reach USD 8460.3 million by 2025. Global Diabetic Neuropathy Market valued approximately USD 4680 million in 2016 is ... Target Audience of the Global Diabetic Neuropathy Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises ...

August 2018 120 pages

U.S. Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patch, CGM System, and Artificial Pancreas), Demographic (Adult Population and Child Population), Indication (Type I Diabetes and Type II Diabetes), and End User (Diagnostics/Clinic, ICU, and Home Healthcare) - U.S. Opportunity Analysis and Industry Forecast, 2014-2023

US$ 3,255.00

... skin irritation due to frequent use of needles. The U.S. next generation diabetes therapy and drug delivery market is segmented based on product type, ... analysis of the key developments in the industry. The U.S. next generation diabetes therapy and drug delivery market is comprehensively analyzed with respect to ...

April 2018 124 pages

Global Human Insulin Market 2018-2024

US$ 2,750.00

... for the manufacturers of human insulin. Market Analysis: The “Global Human Insulin” market is estimated to witness a CAGR of 10.2% during the forecast period 2017–2023. The human insulin market is analyzed based on three ...

February 2018 77 pages

Global Artificial Intelligence in Diabetes Management Market: Drivers, Restraints, Opportunities, Trends, and Forecasts to 2023

US$ 3,500.00

... within 20 years. Market Analysis According to Infoholic Research, the “Global Artificial Intelligence in Diabetes Management” market is expected to grow at a CAGR of 50.7% ... Benefits The study covers and analyzes the “Global Artificial Intelligence in Diabetes Management” market. Bringing out the complete key ...

February 2018 82 pages

Medical Affairs Reputations: Type 2 Diabetes Mellitus [Orals] (EU5) 2018

US$ 6,365.00

... the market leader In the EU5, several of the Type 2 Diabetes Mellitus medical affairs teams we surveyed are running neck and neck with ... ways you can improve your medical affair services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (EU5). Comparing 9 major Type 2 Diabetes Mellitus (Orals) ...

January 2018

Medical Affairs Reputations: Type 2 Diabetes Mellitus [Orals] (US) 2018

US$ 6,365.00

... the ways you can improve your medical affairs services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (US). Comparing 9 major oral Type 2 Diabetes Mellitus treatments from AstraZeneca ...

January 2018

India Diabetes Market Report 2017

US$ 2,350.00

... still maintained a relatively optimistic growth, the past four years, Diabetes market size to maintain the average annual growth rate of 1.96% from 401 ... ) Channel (Direct Sales, Distributor) Segmentation Section 7: 400 USD - Trend (2017-2021) Section 8: 300 USD - Product Type Detail Section 9: 700 ...

November 2017 126 pages

NPS+ Type 2 Diabetes Mellitus [2017] EU5

US$ 2,575.00

... does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (EU5) gives a unique insight into the overall brand health ... degludec/liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (EU5) offers valuable insight into brand loyalty from ...

August 2017

NPS+ Type 2 Diabetes Mellitus [2017] US

US$ 2,575.00

... how does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (US) gives a unique insight into the overall brand health of ... (liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (US) offers valuable insight into brand loyalty from the ...

August 2017

Medical Affairs Reputations: Type 2 Diabetes Mellitus (EU5)

US$ 6,175.00

... what your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (EU5). Comparing 7 major melanoma treatments from Novo ...

June 2017

Medical Affairs Reputations: Type 2 Diabetes Mellitus (US)

US$ 6,175.00

Find out what the leading medical affairs teams in type 2 diabetes are doing right Medical affairs teams for several leading T2DM treatments in the US ... your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (US). Comparing 11 major melanoma treatments from ...

June 2017

Indian Diabetes Market Research and Analysis, 2015-2022

US$ 3,495.00

... India, Pfizer India, Sanofi Aventis, Sun Pharmaceuticals, USV India. Market Segments 1. INDIAN DIABETES MARKET BY TYPE 2. INDIAN DIABETES MARKET BY DRUG CLASS 3. INDIAN DIABETES MARKET BY DEVICES OMR REPORT COVERS: Comprehensive research methodology of Global Indian Diabetes Market ...

May 2017

Diabetic Gastroparesis Forecast in 12 Major Markets 2017-2027

US$ 6,150.00

... also included at a country level across the 10-year forecast snapshot. These gastrointestinal symptoms include: Nausea ... impact from specific co-morbid conditions on Diabetic Gastroparesis prevalent population. Identify sub-populations within Diabetic Gastroparesis which require treatment. Gain an understanding ...

March 2017 50 pages

Type 1 Diabetes Mellitus Forecast in 12 Major Markets 2017-2027

US$ 6,150.00

... at a country level across the 10-year forecast snapshot. There are many co-morbidities associated with Type 1 Diabetes Mellitus, including: Chronic pancreatitis Cystic fibrosis Autoimmune ... on the impact from specific co-morbid conditions on Type 1 Diabetes Mellitus prevalent population. Identify sub-populations within Type 1 Diabetes Mellitus which require treatment. Gain an understanding of the ...

February 2017 54 pages

China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

US$ 1,349.00

... at a time when growth rates in the more developed markets have declined. IMARC’s new report “China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides ...

February 2017 51 pages

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

US$ 1,349.00

IMARC’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both ...

February 2017 49 pages

UK Diabetes Market Report: 2017 - 2022

US$ 1,349.00

IMARC’s new report “UK Diabetes Market Report: 2017 - 2022” provides an analytical and statistical insight into the UK diabetes market. The report provides both current and future trends in the prevalence ...

February 2017 50 pages

Global Diabetes Market: Industry Analysis & Outlook (2016-2020)

US$ 800.00

... seen during pregnancy. The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with the regional markets. The major trends, growth ... profiled. The key factors driving the growth of diabetes market are growing ageing population, growing urbanization, increasing ...

November 2016 107 pages

Analyzing the Global Diabetes Market 2016

US$ 1,000.00

... for diabetes are analyzed in this section. We also look at diabetes epidemiology. Moving to the next section, we analyze the global diabetes market through a market overview and an analysis of the market by diabetes ...

September 2016 195 pages

Global Diabetes Management Market Report 2016

US$ 2,850.00

2016 Global Diabetes Management Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetes Management industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Diabetes Management industry; 3.) the North American Diabetes Management industry; 4.) the European Diabetes Management industry; 5.) market entry and investment feasibility; and ...

August 2016 146 pages

Global Diabetic Food Market Report 2016

US$ 2,850.00

2016 Global Diabetic Food Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetic Food industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Diabetic Food industry; 3.) the North American Diabetic Food industry; 4.) the European Diabetic Food industry; 5.) market entry and investment feasibility; and ...

August 2016 146 pages

US Diabetes Market Report: 2016 - 2020

US$ 1,349.00

... new report “US Diabetes Market Report: 2016 - 2020” provides an analytical and statistical insight into the US diabetes market. The report ... provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in the United States ...

May 2016 44 pages

Global Diabetes Market Research and Analysis, 2014-2020

US$ 3,495.00

Market Insight Global Diabetes Market is expected to grow at a CAGR of 8.1 percent for the forecasted period of 2015-2020. The market is segmented on the basis of type of diabetes, drugs class and ...

May 2016 140 pages

Global Type 1 Diabetes Therapeutics Industry 2015 Market Research Report

US$ 2,850.00

2015 Global Type 1 Diabetes Therapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Type 1 Diabetes Therapeutics industry, focusing on the ... with: 1.) basic information; 2.) the Asia Type 1 Diabetes Therapeutics industry; 3.) the North American Type 1 Diabetes Therapeutics industry; 4.) the European Type 1 Diabetes Therapeutics industry; 5.) market entry and investment feasibility ...

December 2015 161 pages

India Diabetes Management Devices Market Forecast and Opportunities, 2020

US$ 2,500.00

... . “India Diabetes Management Devices Market & Opportunities, 2020” elaborates the following aspects of diabetes management devices market in India: India Diabetes Management Devices Plastic Market Size, Share & Forecast Segmental Analysis – Diabetes Monitoring Devices and Diabetes Management Delivery Devices ...

December 2015 89 pages

US Diabetes Market Outlook 2020

US$ 1,000.00

... diabetes and pre-diabetes are found in the United States, with many still unaware about their diabetes or pre-diabetes ... diabetic drugs. The report, “US Diabetes Market Outlook 2020”, highlights the US diabetes market by each segment. The market for each segment has been thoroughly studied and the future market ...

July 2015 85 pages

Physician Views: Five key diabetes market questions ahead of ADA 2014

US$ 695.00

... product to Lantus now known as Toujeo. See Physician Views Poll Results – Usage of Sanofi's U300 will not ... this point. In the oral diabetes market, there are two key trends to watch. In the GLP ... , FirstWord is polling US and EU5-based endocrinologists on five key questions ahead of the ADA meeting, Specifically ...

April 2015

FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (EU5)

US$ 4,995.00

What market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to availability to reimbursement factors, FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (EU5) provides insights that can help develop, shape and refine your brand strategies. Also Available is FirstView Barriers – An Analysis ...

April 2015

FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (US)

US$ 4,995.00

What environmental market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to availability to reimbursement factors, FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (US) provides insights that can help develop, shape and refine your brand strategies. Also Available is FirstView Barriers – An Analysis of Market Barriers ...

April 2015

Physician Views: What Commercial Impact for Eylea from the Protocol T Study in Diabetic Macular Oedema?

US$ 695.00

... 's Eylea). Converting any clinical advantage to the commercial setting may prove challenging, however, ... injection for Eylea. To better ascertain the impact of the Protocol T study results on uptake of Eylea, ... treatment of DME? In the first-line setting, what level of overall switching (or alternative new start ...

April 2015

Physician Views: How do endocrinologists value diabetes-focused medical affairs teams – what could they be doing better?

US$ 695.00

... and value of these teams. FirstWord's latest Physician Views poll seeks to gain some insight into how endocrinologists value the role that medical affairs ... asking US and EU5-based physicians: How important they view medical affairs teams in enabling effective communication between physicians and pharmaceutical companies? Which activities ...

December 2014

HbA1c Testing Market in India 2014

US$ 950.00

... in 0-2 business days after order is placed. Netscribes’ latest market research report titled HbA1c Testing Market in India 2014 states that with the increasing incidence of diabetes ...

September 2014 132 pages

US Diabetes Monitoring, Treatment and Drug Delivery Market - 2014

US$ 6,995.00

... growing segments included the continuous glucose monitoring (CGM), insulin pump and supplies, modern insulin, insulin pens and pen needle markets. These segments have one aspect in common: they are newer ways of treating diabetes. CGM and pump technologies are improving at a fast pace toward full integration ...

April 2014 212 pages

Diabetes - KOL Insight and Consensus Outlook Modules

US$ 7,495.00

... term: battle lines are drawn The fundamental drivers of the global diabetes market are strong and continue to fuel growth. Rising levels ... comprehensive FirstWord research is available in two comprehensive modules: The KOL Insight: Diabetes module provides a complete review and is enhanced with exclusive ...

February 2014 224 pages

UAE Diabetes Market Opportunity Analysis 2018

US$ 600.00

... diabetes care. “UAE Diabetes Market Opportunity Analysis 2018” gives comprehensive insight on following aspects related to pharmaceutical market: Market Overview Diabetes Prevalence Diabetes Drug Market Insulin Delivery Devices Market Glucose Monitoring Devices Market Diabetes Market ...

January 2014 33 pages

China Diabetes Market Outlook 2018

US$ 1,000.00

... to reach approximately US$ 4.6 Billion by 2018. In RNCOS’ latest report “China Diabetes Market Outlook 2018”, the country’s diabetes market has been segmented ... been extending their product portfolios in order to gain their own market shares. In the end, RNCOS concludes with a competitive analysis of major ...

October 2013 50 pages

TAKEDA, Vortioxetine (Brintellix) – US Approval for MDD Likely in October – Competitive Enough Against Genericized MDD Market, Yet Maturing Late Stage Pipeline Candidates Warrant A Close Watch!

US$ 140.00

Takeda’s late stage pipeline candidate – Vortioxetine (Filed, Partnered with Lundbeck, US PDUFA on October 2nd) is expected to get ... present an attractive market for new entrants. Reported PhIII data of Vortioxetine look. However, other pipeline candidates are chasing ...

August 2013 4 pages

Diabetes: Battle for ascendancy escalates in expanding market – KOL Insight

US$ 4,995.00

... ; Novo Nordisk) recent US failure, the exponential market growth makes diabetes one of the most attractive opportunities in Pharma. Competition in the major ... market share from the gold standard treatments. ‘Therapy Trends: Diabetes’ is compiled from exclusive, in-depth interviews with the world’s leading ...

July 2013

Physician Views: Which diabetes company does the best marketing job? What is key for companies launching products?

US$ 695.00

... run in January looking at physician detailing, this week’s FirstWord Physician Views poll investigates which companies are best at physician marketing in the diabetes space. Notably, failure to gain ... endocrinologists, which are the best detailing diabetes companies and drugs and what factors support this view. This week's FirstWord Physician Views poll will ...

July 2013

Physician Views: Post ADA view on key diabetes market developments

US$ 695.00

... to extend and enhance its market-leading Lantus franchise. At the ADA meeting, Sanofi released the first Phase III data for ... patent expiry date is feasible. In light of recent developments, this week’s Physician Views poll will ask US-based endocrinologists: Whether they anticipate data ...

June 2013

Filters

Search

Publishers

1
2
3
1
1
1
1
2
1
2
1
1
3
3
1
1
1
16
1
2
4
1
4
1
8
4

Regions

1
4
1
4
2
6
4
45

Price

Date

Pages

Offers